Medical Fluorescence Immunoassay Analyzer Lab Hospital

Reliable:

• Use FIA technology with high sensitivity and accuracy
• single test or batch test available

​Fast:

• The result can be get in 3~15 min
• 24 h/day standby

Convenient:

• Compact design of the analyzer for POCT
• Reagent information is scanned automaticly

Easy operation:

• Boot up and log in
• Input sample information
• Read reagent’s ID card for calibration info
• Insert the reagent strip 
• Prepare and add sample into the reagent strip
• Room temperature
• Start testing
• Result in 3-15 minutes
•  

Lab&Hospital Medical Analyzer Fluorescence Immunoassay (FIA) Platform-YFA 100

Product parameters:

Introduction

YFA100 is a portable POCT system with fluorescence immunochromatographic principle. It can provide reliable quantitative test results in 3-15 minutes on the spot, assisting the clinical diagnosis of inflammation, cardiovascular diseases, renal injury etc., and public health fields such as clinical testing, health management, epidemic control, food safety monitoring are available.YFA 100 is applicable for clinics, doctor's offices, frontline health services and various hospital departments, as well as a supplement in laboratories.

Features:

Test menu:

• Inflammation: PCT, CRP, SAA, HBP*, CRP/SAA*, PCT/IL6*
• Cardiac Markers: cTnI, NT-proBNP, D-Dimer, CK-MB*, Myo*, cTnI/NT-proBNP*, cTnI/CK-MB/Myo*
• Kidney Function: CysC, β2-MG
• Fertility: AMH*, β-HCG*, PAPP-A*
• Bone Metabolism: 25-OH-VD*, PTH*

Company profile

Aikang Group is a national high-tech company specialized in R&D, production, sales and service of medical devices. Founded in 2003, Aikang is headquartered in Shenzhen China and has established three R&D and production bases with a total area of 30,000 square meters and hundreds of employees.

Aikang has three Manufacture Bases:

Aikang MedTech Co., Ltd. for medical automation solutions, Aikang Diagnostic Co., Ltd. for in-vitro diagnostic solutions and Aisikang MedTech Co., Ltd. for medical consumables.

Aikang is always focusing on innovation and quality, constantly communicating with partners from Germany, Switzerland etc., and insisting on developing products under international standards with its own intellectual properties. Every year, over 10% of sales revenue is invested in R&D. By 2020, Aikang has achieved 187 patents applied and certificates of ISO, CE etc.